Zinc control could be path to breast cancer treatment

The body's control mechanisms for delivering zinc to cells could be key to improving treatment for some types of aggressive breast cancer.

New research by Cardiff University and King's College London has identified the switch which releases into cells, with important implications for a number of diseases.

Zinc has long been known to play a vital part in human health. Too much zinc, or too little, can cause . A growing body of evidence links zinc to disease states including neurodegeneration, inflammation, diabetes and cancer.

Zinc levels in cells are controlled by called zinc transporters. These move zinc in and out of the cell to ensure correct levels are maintained. Until now, scientists have not understood how the transporters release the zinc. The Cardiff and King's research team have identified a switch, known as CK2, a protein which opens one transporter, called ZIP7, and allows the zinc to flow.

Earlier research by the team has already linked zinc delivery to types of breast cancer. Higher levels of intracellular zinc and the ZIP7 transporter were found in tamoxifen-resistant breast cancers. CK2 was also known to be more common in cancers which encourage cell growth. The discovery that CK2 opens ZIP7 suggests that drugs which block this release of zinc could also block . Early results from clinical trials of CK2 inhibitors suggest they are performing well.

Dr Kathryn Taylor, of Cardiff University's School of Pharmacy and , said: "We know that zinc, in the right quantities, is vital for development, our immune systems and many other aspects of human health. But when something goes wrong with the body's zinc delivery system, it looks as though disease can result. In particular, our research has shown a link to highly aggressive forms of . Our better understanding of how exactly zinc is delivered suggests if we can block malfunctioning transporter channels, we can potentially halt the growth of these forms of cancer. We believe this makes zinc, and zinc delivery, a high priority for future cancer research."

Professor Christer Hogstrand from the Diabetes and Nutritional Sciences Division at King's College London, said: "Our discovery provides a mechanistic explanation for how the cell uses zinc to regulate different functions. The evidence that zinc is released on command in the cell and then regulates cellular processes seems to set it apart from other transition metals, such as copper and iron, in the way that it is used by the body. These findings should open the door for new research into the roles of zinc in health and disease."

The research, funded by a Wellcome Trust University Research Award to Dr Taylor, is published tomorrow (February 7) in the leading journal Science Signaling.

Related Stories

Zinc transporters regulate pancreatic cancer

date Nov 12, 2007

Zinc, an important trace element for healthy growth and development, can be related to pancreatic cancer. Too much ZIP4, a molecule that enables the transport of zinc into cells, promotes the growth and spread of pancreatic ...

Zinc lozenges may shorten common-cold duration

date Jul 26, 2011

Depending on the total dosage of zinc and the composition of lozenges, zinc lozenges may shorten the duration of common cold episodes by up to 40%, according to a study published in the Open Respiratory Medicine Journal.

Zinc lozenges may shorten common cold duration

date Aug 16, 2011

Depending on the total dosage of zinc and the composition of lozenges, zinc lozenges may shorten the duration of common cold episodes by up to 40%, says Dr. Harri Hemila from the University of Helsinki.

Recommended for you

DNA blood test detects lung cancer mutations

date 14 hours ago

Cancer DNA circulating in the bloodstream of lung cancer patients can provide doctors with vital mutation information that can help optimise treatment when tumour tissue is not available, an international group of researchers ...

Tumors prefer the easy way out

date 17 hours ago

Tumor cells become lethal when they spread. Blocking this process can be a powerful way to stop cancer. Historically, scientists thought that tumor cells migrated by brute force, actively pushing through whatever ...

Brain tumors may be new targets of Ebola-like virus

date 17 hours ago

Brain tumors are notoriously difficult for most drugs to reach, but Yale researchers have found a promising but unlikely new ally against brain cancers—portions of a deadly virus similar to Ebola.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.